4.7 Article

A Smart pH-Sensitive Delivery System for Enhanced Anticancer Efficacy via Paclitaxel Endosomal Escape

期刊

FRONTIERS IN PHARMACOLOGY
卷 10, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2019.00010

关键词

pH-sensitive; micelles; cancer; paclitaxel; endosomal escape

资金

  1. Innovation-Driven Project of Central South University [20170030010004]
  2. National Natural Science Foundation of China [81573374, 81502997]
  3. Key Laboratory Breeding Base of Hunan Oriented Fundamental and Applied Research in Innovative Pharmaceutics [2016TP1029]
  4. Hunan Engineering Research Center for Optimization of Drug Formulation and Early Clinical Evaluation [2015TP2005]
  5. Director Fund of Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy [ZR-XY201406]

向作者/读者索取更多资源

Micelles are highly attractive nano-drug delivery systems for targeted cancer therapy. While they have been demonstrated to significantly alleviate the side-effects of their cargo drugs, the therapy outcomes are usually suboptimal partially due to ineffective drug release and endosome entrapment. Stimulus-responsive nanoparticles have allowed controlled drug release in a smart fashion, and we want to use this concept to design novel micelles. Herein, we reported pH-sensitive paclitaxel (PTX)-loaded poly (ethylene glycol)-phenylhydrazone-dilaurate (PEG-BHyd-dC12) micelles (PEG-BHyd-dC12/PTX). The micelles were spherical, with an average particle size of similar to 135 nm and a uniform size distribution. The pH-responsive properties of the micelles were certified by both colloidal stability and drug release profile, where the particle size was strikingly increased accompanied by faster drug release as pH decreased from 7.4 to 5.5. As a result, the micelles exhibited much stronger cytotoxicity than the pH-insensitive counterpart micelles against various types of cancer cells due to the hydrolysis of the building block polymers and subsequent rapid PTX release. Overall, these results demonstrate that the PEG-BHyd-dC12 micelle is a promising drug delivery system for cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据